Order results by:
| Issue | Title | |
| Vol 19, No 4 (2023) | Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy | Abstract similar documents |
| S. R. Gilyarevsky, D. O. Ladygina | ||
| "... (MRAs), in particular spironolactone, in the treatment of hyperaldosteronism and resistant hypertension ..." | ||
| Vol 16, No 4 (2020) | In the Refractory Hypertension “Labyrinth”. Focus on Primary Hyperaldosteronism | Abstract similar documents |
| O. V. Tsygankova, T. I. Batluk, L. D. Latyntseva, E. V. Akhmerova, N. M. Akhmedzhanov | ||
| "... Primary hyperaldosteronism is an existence of a functional autonomous source with increased ..." | ||
| Vol 6, No 1 (2010) | EVOLUTION STAGES OF LOW RENIN HYPERTENSION | Abstract similar documents |
| S. V. Akhadov, G. R. Ruzbanova, G. S. Molchanovа | ||
| "... ) and plasma aldosterone level (PAL) were determined by radioimmunoassay method in active patients. 24-hour ..." | ||
| Vol 13, No 2 (2017) | ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE | Abstract similar documents |
| V. I. Podzolkov, N. A. Dragomiretskaya | ||
| "... The importance of renin-angiotensin-aldosterone system in pathogenesis of different clinical ..." | ||
| Vol 12, No 4 (2016) | Resistant hypertension: epidemiology and risk factors | Abstract similar documents |
| I. E. Deneka, A. A. Svetankova, A. V. Rodionov | ||
| "... , obstructive sleep apnea syndrome and primary hyperaldosteronism. Understanding these mechanisms of resistance ..." | ||
| Vol 20, No 4 (2024) | Baxdrostat and finerenone: new aldosterone synthase-aldosterone-mineralocorticoid receptor hormonal system inhibitors for the drug treatment of resistant arterial hypertension | Abstract similar documents |
| O. B. Kuzmin, N. V. Buchneva, V. V. Belyanin, V. V. Zhezha, M. V. Stolbova | ||
| "... aldosterone production and normal or even decreased renin plasma activity. A key role in its formation ..." | ||
| Vol 11, No 2 (2015) | A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE | Abstract similar documents |
| B. B. Gegenava, O. M. Drapkina | ||
| "... The role of aldosterone in pathophysiological processes is considered. The effects ..." | ||
| Vol 6, No 3 (2010) | THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| V. I. Podzolkov, A. E. Bragina, Ju. N. Rodionova, E. K. Panferova | ||
| "... Aim. To study the correlation of the renin-angiotensin-aldosterone system (RAAS) activity ..." | ||
| Vol 6, No 2 (2010) | REFRACTORY HYPERTENSION – MODERN APPROACHES TO DIAGNOSTICS AND TREATMENT | Abstract similar documents |
| A. N. Britov, M. M. Bystrova | ||
| "... causes (sleep apnea syndrome, kidney diseases, renal artery stenosis, and primary hyperaldosteronism ..." | ||
| Vol 8, No 3 (2012) | EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES | Abstract similar documents |
| O. A. Koshel'skaya, O. A. Zhuravleva | ||
| "... antihypertensive therapy with or without renin-angiotensin-aldosterone system (RAAS) inhibitors. Material ..." | ||
| Vol 8, No 1 (2012) | CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1 | Abstract similar documents |
| V. V. Popov, N. A. Bulanov, G. G. Ivanov | ||
| "... inhibit renin–angiotensin–aldosterone system (RAAS). Novel targets for antihypertensive therapy could ..." | ||
| Vol 8, No 2 (2012) | CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2 | Abstract similar documents |
| V. V. Popov, N. A. Bulanov, G. G. Ivanov | ||
| "... inhibit renin–angiotensin–aldosterone system (RAAS). Novel targets for antihypertensive therapy could ..." | ||
| Vol 12, No 6 (2016) | CHRONIC HEART FAILURE: CLINICAL GUIDELINES AND REAL CLINICAL PRACTICE | Abstract similar documents |
| E. K. Shavarova, L. A. Babaeva, S. S. Padaryan, N. N. Soseliya, O. I. Lukina, A. S. Milto | ||
| "... antagonists (MRA) received spironolactone. During hospitalization 81% of HFrEF patients received ACEI therapy ..." | ||
| Vol 10, No 3 (2014) | RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING | Abstract similar documents |
| V. S. Pykhtina, I. D. Strazhesko, M. V. Agaltsov, O. N. Tkacheva | ||
| "... is paid to the activation of the renin-angiotensin-aldosterone system as a source of chronic inflammation ..." | ||
| Vol 13, No 3 (2017) | BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL | Abstract similar documents |
| I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov | ||
| "... retention, and the activation of renin-angiotensin-aldosterone and sympathoadrenal systems. Carvedilol ..." | ||
| Vol 4, No 1 (2008) | COMPARATIVE ANALYSIS OF LOSATAN AND ENALAPRIL ANTIHYPERTENSIVE EFFICACY (ELLA TRIAL) | Abstract similar documents |
| N. M. Chihladze, O. A. Sivakova, H. F. Samedova, G. N. Litonova, E. B. Yarovaya, I. E. Chazova | ||
| "... . Microalbuminuria (MAU) levels, plasma aldosterone levels and plasma renin activity were estimated. Results. Target ..." | ||
| Vol 8, No 6 (2012) | SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| K. A. Gyamdzhyan, M. L. Maksimov | ||
| "... -angiotensin-aldosterone system are discussed. Efficacy and safety of two major cardiovascular drug classes ..." | ||
| Vol 16, No 5 (2020) | The Role of Adherence to Basic Pharmacotherapy of Heart Failure for Prevention of Late Adverse Events in Patients with Coronary Artery Disease and Left Ventricular Dysfunction After Surgical Revascularization of Myocardium | Abstract PDF (Eng) similar documents |
| O. A. Yepanchintseva, K. A. Mikhaliev, I. V. Shklianka, O. J. Zharinov, B. M. Todurov | ||
| "... blockers), beta-blockers (BBs; 97.6%) and mineralocorticoid receptors antagonists (MRAs; 79.0%), being ..." | ||
| Vol 18, No 2 (2022) | Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 2: Correction of Myocardial Systolic Dysfunction | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva | ||
| "... to standard therapy, compared with patients without aldosterone antagonists. ..." | ||
| Vol 12, No 3 (2016) | GENETIC PREDICTORS OF ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
| A. V. Kuskaeva, S. Yu. Nikulina, A. A. Chernova, N. V. Aksyutina | ||
| "... the development of AF. The study of genes of renin-angiotensin-aldosterone system (RAAS) is especially important ..." | ||
| Vol 16, No 4 (2020) | Evaluating Adherence to Medical Therapy in Patients with Chronic Heart Failure: Design and First Results of the COMPLIANCE Study | Abstract similar documents |
| S. Yu. Martsevich, E. T. Guseynova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, S. V. Blagodatskih | ||
| "... , and mineralocorticoid receptor antagonists (MRAs) – to 76.7% of patients, and some of them received MRAs at ejection ..." | ||
| Vol 17, No 2 (2021) | Treatment of Resistant Hypertension in Real Clinical Settings | Abstract similar documents |
| A. S. Maltseva, A. E. Tsygankova, M. A. Gabitova, A. V. Rodionov, V. V. Fomin | ||
| "... (mineralocorticoid receptors antagonist [MRA], beta-blocker, alpha-blocker, agonist of imidazoline receptors [AIR ..." | ||
| Vol 21, No 1 (2025) | Physicians’ knowledge of therapy that affecting the prognosis of patients with chronic heart failure | Abstract similar documents |
| N. B. Perepech, I. E. Mikhailova, A. V. Tregubov | ||
| "... antagonist (MRA) + sodium- glucose cotransporter type 2 inhibitor (SGLT2i) was named as an optimal treatment ..." | ||
| Vol 13, No 3 (2017) | ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION | Abstract similar documents |
| V. I. Podzolkov, M. V. Pisarev | ||
| "... An increase in the activity of the renin-angiotensin-aldosterone system is one of the most ..." | ||
| Vol 13, No 4 (2017) | PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY | Abstract similar documents |
| O. M. Drapkina, D. U. Akasheva | ||
| "... and renin-angiotensin-aldosterone, is the basis of modern concepts of the pathogenesis of heart failure ..." | ||
| Vol 8, No 4 (2012) | UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION | Abstract similar documents |
| E. A. Protasova, N. V. Furman, O. V. Reshet'ko | ||
| "... Inhibitors of the renin-angiotensin-aldosterone system, statins, and possibly , ω-3 ..." | ||
| Vol 6, No 4 (2010) | LISINOPRIL IMPLICATION IN THE CLINICAL PRACTICE | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... -aldosterone system (RAAS) play a key role in the pathogenesis of the cardiovascular continuum. The first drugs ..." | ||
| Vol 17, No 2 (2021) | The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19 | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... of the cardiovascular system, which has a variety of mechanisms: dysregulation of the renin-angiotensin-aldosterone ..." | ||
| Vol 20, No 3 (2024) | BRASH syndrome: а clinical case | Abstract similar documents |
| D. D. Shalaeva, K. G. Pereverzeva, O. A. Fomina, S. S. Yakushin | ||
| "... ). Pulse-reducing drugs, blockers of the renin-angiotensin-aldosterone system were canceled for the patient ..." | ||
| Vol 18, No 1 (2022) | Polymorbidity and Polypragmasia in High and Very High Cardiovascular Risk Patients | Abstract similar documents |
| N. V. Izmozherova, A. A. Popov, A. A. Kuryndina, E. I. Gavrilova, M. A. Shambatov, V. M. Bakhtin | ||
| "... . Thus, 87.5% CHF patients were receiving renin-angiotensin-aldosterone system blockers. Statins were ..." | ||
| Vol 15, No 3 (2019) | Hypertension and Headache: the Effect of Antihypertensive Drugs | Abstract similar documents |
| V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova | ||
| "... of hyperactivation of the renin-angiotensin-aldosterone and adrenergic system and endothelial dysfunction ..." | ||
| Vol 16, No 3 (2020) | The Possibilities of Single-Pill Combinations of Antihypertensive Drugs in Cerebroprotection: Focus on the Combination of Amlodipine with Ramipril | Abstract similar documents |
| A. I. Kochetkov, S. V. Batyukina, O. D. Ostroumova, M. Yu. Nazranova, V. N. Butorov | ||
| "... -aldosterone system, as well as target-organ damage - primarily the heart in the form of left ventricular ..." | ||
| Vol 10, No 5 (2014) | CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE | Abstract similar documents |
| S. V. Gatsura, O. A. Gatsura, A. N. Golosova | ||
| "... popular medications (р<0.01). Conclusion. Blockers of renin-angiotensin-aldosterone system remain ..." | ||
| Vol 9, No 6 (2013) | DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, A. D. Deev, S. A. Boytsov | ||
| "... .6% to 69.3% in women in last 5 years. Incidence of the renin-angiotensin-aldosterone system blockers intake ..." | ||
| Vol 17, No 1 (2021) | Pharmacogenetics as a Way for Personalizing Diuretic Therapy: Focus on Torasemide | Abstract similar documents |
| N. M. Gafurova, E. V. Shikh, O. D. Ostroumova | ||
| "... in a decrease of sympathetic activity and inhibition of the renin-angiotensin-aldosterone system, leads ..." | ||
| Vol 17, No 2 (2021) | Current Guidelines for the Treatment of Arterial Hypertension in Patients with Diabetes Mellitus and Chronic Kidney Disease | Abstract similar documents |
| T. Yu. Demidova, O. A. Kislyak | ||
| "... -aldosterone system (an angiotensin-converting enzyme inhibitor [ACE inhibitor] or an angiotensin II receptor ..." | ||
| Vol 15, No 2 (2019) | Cognitive impairment in patients with arterial hypertension: a relationship with the level and daily blood pressure profile and pathogenetic mechanisms | Abstract similar documents |
| T. M. Ostroumova, V. A. Parfenov, O. D. Ostroumova | ||
| "... systems (renin-angiotensin-aldosterone and sympathoadrenal, hypothalamic-pituitary-adrenal system ..." | ||
| Vol 15, No 5 (2019) | Modern Principles of Treatment of Uncontrolled Hypertension | Abstract similar documents |
| V. I. Podzolkov, A. I Tarzimanova, Z. O. Georgadze | ||
| "... of arterial hypertension in 2018, remain a combination of blockers of the renin-angiotensin-aldosterone system ..." | ||
| Vol 13, No 1 (2017) | EVALUATION OF TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION BEFORE REFERENCE EVENT AND BEFORE DISCHARGE FROM THE HOSPITAL: REGISTER DATA (KHABAROVSK CITY). PART 2 | Abstract similar documents |
| L. N. Malay, S. Yu. Martsevich, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, N. B. Garayeva, A. Ya. Letskin | ||
| "... .5%; renin-angiotensin-aldosterone system inhibitors – in 90.6%. A total lethality in STEMI was 15 ..." | ||
| Vol 10, No 3 (2014) | THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) | Abstract similar documents |
| M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev | ||
| "... receiving b-blockers, 35.3% - renin-angiotensin-aldosterone system (RAAS) inhibitors, 15.7% - antiplatelet ..." | ||
| Vol 8, No 5 (2012) | EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS | Abstract similar documents |
| O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov | ||
| "... -angiotensin-aldosterone system (RAAS) blockers, indapamide and calcium channel blocker (CCB) in hypertensive ..." | ||
| Vol 14, No 5 (2018) | Associations of Cardiovascular Risk Factors and Genetic Markers with Development of Arterial Hypertension in the Population of Mountain Shoriya | Abstract similar documents |
| T. A. Mulerova, S. A. Maksimov, M. Yu. Ogarkov, O. V. Gruzdeva, A. V. Ponasenko, V. N. Maksimov, M. I. Voyevoda, E. S. Filimonov, G. V. Artamonova | ||
| "... the proteins of the main components of neurophysiological systems (renin-angiotensin-aldosterone, sympathetic ..." | ||
| Vol 17, No 1 (2021) | Treatment Adherence to Drug Therapyin Patients with Stable Coronary Artery Disease During the COVID-19 Pandemic | Abstract PDF (Eng) similar documents |
| S. Y. Martsevich, Y. V. Lukina, E. D. Zharkova, N. P. Kutishenko | ||
| "... -aldosterone system inhibitors and dihydropyridine calcium antagonists remained unchanged. Conclusion ..." | ||
| Vol 16, No 1 (2020) | An Attempt to Accord the Quality of Therapy of Stable Coronary Heart Disease Patients with Current Clinical Guidelines (ALIGN study): Design and the First Results | Abstract similar documents |
| S. Yu. Martsevich, E. D. Zharkova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, A. V. Zagrebelnyy | ||
| "... %, and renin-angiotensin-aldosterone system (RAAS) blockers – in 80% of cases. Conclusions. Initial quality ..." | ||
| Vol 15, No 5 (2019) | Outpatient Register of Patients with Acute Myocardial Infarction: Assessment of the Hypertension Impact on Long-term Prognosis | Abstract similar documents |
| D. P. Sichinava, E. P. Kalaydzhyan, N. P. Kutishenko, S. Yu. Martsevich | ||
| "... AMI, the frequency of their use was low: renin-angiotensin-aldosterone system blockers were prescribed ..." | ||
| 1 - 45 of 45 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
